[1]夏露,朱小明,李苏宜,等.院内鼻咽癌患者营养管理的研究进展[J].肿瘤学杂志, 2023, 29(12): 1049-1059. DOI:10.11735/j.issn.1671-170X.2023.12.B010.
[2]Liu H, Yang P, Jia Y. Optimal management of oligometastatic nasopharyngeal carcinoma[J]. Eur Arch Otorhinolaryngol, 2022, 279(2): 567-576. DOI: 10.1007/s00405-021-06918-y.
[3]董怡君,宋柳,景星滔,等. «2023NCCN头颈癌临床实践指南(第1版)»更新解读[J].西部医学, 2023, 35(10): 1412-1417. DOI:10.3969/j.issn.1672-3511.2023.10.002.
[4]Wang WH, Yeh CF, Lan MY. The role of nasopharyngectomy in the management of nasopharyngeal carcinoma[J]. Curr Opin Otolaryngol Head Neck Surg, 2022, 30(1): 3-12. DOI: 10.1097/MOO.0000000000000780.
[5]Wong KCW, Hui EP, Lo KW, et al. Nasopharyngeal carcinoma: an evolving paradigm[J]. Nat Rev Clin Oncol, 2021, 18(11): 679-695. DOI: 10.1038/s41571-021-00524-x.
[6]于明艳,王婷婷,杜鸣宇,等.基于SEER数据库的大样本人群中UICC/AJCC第8版分期鼻咽癌Ⅲ期预后分析[J].肿瘤学杂志, 2023, 29(6): 502-510. DOI:10.11735/j.issn.1671-170X.2023.06.B009.
[7]Yang G, Luo B, Yang Q, et al. Construction of nomograms for nasopharyngeal carcinoma containing primary tumor size and SEER stage[J]. Transl Cancer Res, 2020, 9(11): 6939-6954. DOI: 10.21037/tcr-20-2080.
[8]马飞飞,彭鹏,劳家辉,等.基于SEER数据库分析癌症患者自杀率的长期趋势[J].中华肿瘤防治杂志, 2022, 29(4): 248-252. DOI: 10.16073/j.cnki.cjcpt.2022.04.03.
[9]Butler EN, Zhou CK, Curry M, et al. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database[J]. Br J Cancer, 2023, 128(1): 48-56. DOI: 10.1038/s41416-022-02019-7.
[10]杨成盛,黄士浦,刘佳艺,等.鼻咽癌免疫治疗研究进展[J].华夏医学,2024,37(2): 31-36. DOI: 10.19296/j.cnki.1008-2409.2024-02-005.
[11]邬要芬,冯燕英,时光,等.鼻咽癌患者同步放化疗期间症状群的变化研究[J].国际医药卫生导报,2023,29(5): 717-722. DOI: 10.3760/cma.j.issn.1007-1245.2023.05.029.
[12]Qiao H, Tan XR, Li H, et al. Association of intratumoral microbiota with prognosis in patients with nasopharyngeal carcinoma from 2 hospitals in China[J]. JAMA Oncol, 2022, 8(9): 1301-1309. DOI: 10.1001/jamaoncol.2022.2810.
[13]汪德辉,王中亮.鼻咽癌放疗后并发症研究进展[J].中国医学文摘(耳鼻咽喉科学), 2024, 39(1): 180-184.
[14]陈春兰,李素霞.个案管理师在鼻咽癌患者全病程个案管理中的临床实践效果[J].国际医药卫生导报, 2022, 28(1): 131-136. DOI: 10.3760/cma.j.issn.1007-1245.2022.01.034.
[15]Toumi N, Ennouri S, Charfeddine I, et al. Prognostic factors in metastatic nasopharyngeal carcinoma[J]. Braz J Otorhinolaryngol, 2022, 88(2): 212-219. DOI: 10.1016/j.bjorl.2020.05.022.
[16]Xiao XT, Wu YS, Chen YP, et al. Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy[J]. Cancer Med, 2023, 12(2): 1399-1408. DOI: 10.1002/cam4.5020.
[17]He Y, Chen X, Yang T, et al. Nutritional intervention for the prognosis of nasopharyngeal carcinoma chemoradiotherapy patients: a meta-analysis[J]. Medicine (Baltimore), 2023, 102(41): e35386. DOI: 10.1097/MD.0000000000035386.
[18]黎润球,陈顺金,郑锐年.东莞市鼻咽癌患者家族癌症发病史流行病学调查分析[J].公共卫生与预防医学, 2021,32(5): 138-140. DOI: 10.3969/j.issn.1006-2483.2021.05.032.
[19]吕昀鸿,林爱华.鼻咽癌的危险因素研究进展[J].中国医院统计,2021,28(2): 188-192. DOI: 10.3969/j.issn.1006-5253.2021.02.022.
[20]王晓莉,杨宏伟,丁婷,等.云南籍鼻咽癌患者2 499例的临床资料分析[J].昆明医科大学学报, 2023, 44(5): 154-161. DOI: 10.12259/j.issn.2095-610X.S20230523.
[21]Huang H, Yao Y, Deng X, et al. Immunotherapy for nasopharyngeal carcinoma: current status and prospects (Review)[J]. Int J Oncol, 2023, 63(2): 97. DOI: 10.3892/ijo.2023.5545.
[22]Chen P, Liu B, Xia X, et al. Current progress in immunotherapy of nasopharyngeal carcinoma[J]. Am J Cancer Res, 2023, 13(4): 1140-1147.
[23]Chang ET, Ye W, Zeng YX, et al. The evolving epidemiology of nasopharyngeal carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2021, 30(6): 1035-1047. DOI: 10.1158/1055-9965.EPI-20-1702.
[24]翁敬锦,高俊潇,李敏,等.鼻内镜手术联合化疗与手术联合放疗对高发区早期鼻咽癌患者预后的影响[J].临床耳鼻咽喉头颈外科杂志, 2024, 38(6): 472-476, 484. DOI:10.13201/j.issn.2096-7993.2024.06.004.
[25]Chen H, Huang Z, Chen L, et al. Characteristics of early death in patients with localized nasopharyngeal cancer: a population-based SEER analysis[J]. Front Oncol, 2021, 11: 580220. DOI: 10.3389/fonc.2021.580220.
[26]Diaz A, Bujnowski D, Chen H, et al. Health insurance coverage and survival outcomes among nasopharyngeal carcinoma patients: a SEER retrospective analysis[J]. J Neurol Surg B Skull Base, 2022, 84(3): 240-247. DOI: 10.1055/s-0042-1747962.
[27]代红磊,王秋阳,马文学,等.基于Joinpoint回归及年龄-时期-队列模型分析鼻咽癌患者的死亡率发展趋势[J].山东大学耳鼻喉眼学报,2024,38(1): 27-31. DOI:10.6040/j.issn.1673-3770.0.2022.440.
|